First and Only AI-Simulated Roleplay Solution Exclusively Designed for Pharmaceutical Field Professionals, Awarded for AI ...

The deal gives Mirum access to Bluejay’s monoclonal antibody brelovitug, which is currently in Phase III trials.

The biannual AustinPx Amorphous Solid Dispersions (ASD) Workshop is a place for collaboration and innovation. Hear firsthand ...

Inductive Bio has secured up to $21m in funding from ARPA-H to lead the development of AI drug-toxicity prediction models.

If passed into law, the BIOSECURE Act would have a major impact on US-China relationships in the pharma industry.

Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic ...

This comes just under a month after Pfizer finalised a deal to acquire Metsera following a bidding war with Novo Nordisk.

Nearly one in four European pharmaceutical companies remains vulnerable to regulatory risks due to inadequate quality systems ...

The discovery, featured on the cover of Analytical Chemistry, could potentially slow the progression to full-blown diabetes.

Experts have called for technology adoption in Nigeria’s healthcare transformation and prioritisation of patient-centred ...

Rapid three-week deployment, onsite support from two-time Nobel Laureate, and deep Canada-Korea collaboration underscore ...

SHELTON, CT, December 9, 2025 (EZ Newswire) -- NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) today reported that ...